Patents by Inventor Stanislav Ivanovich Tomarev

Stanislav Ivanovich Tomarev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Exosomes and miRNA to treat glaucoma
    Patent number: 11806369
    Abstract: Methods are disclosed herein for treating glaucoma in a subject. In some embodiments, the methods increase retinal ganglion cell survival. The disclosed methods use exosomes and/or miRNA.
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: November 7, 2023
    Assignee: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services
    Inventors: Stanislav Ivanovich Tomarev, Benjamin Frank John Martin Mead
  • EXOSOMES AND MIRNA TO TREAT GLAUCOMA
    Publication number: 20210292758
    Abstract: Methods are disclosed herein for treating glaucoma in a subject. In some embodiments, the methods increase retinal ganglion cell survival. The disclosed methods use exosomes and/or miRNA.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Applicant: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Stanislav Ivanovich Tomarev, Benjamin Frank John Martin Mead
  • Exosomes and miRNA to treat glaucoma
    Patent number: 11058729
    Abstract: Methods are disclosed herein for treating glaucoma in a subject. In some embodiments, the methods increase retinal ganglion cell survival. The disclosed method use exosomes and/or miRNA.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: July 13, 2021
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Stanislav Ivanovich Tomarev, Benjamin Frank John Martin Mead
  • EXOSOMES AND MIRNA TO TREAT GLAUCOMA
    Publication number: 20190224242
    Abstract: Methods are disclosed herein for treating glaucoma in a subject. In some embodiments, the methods increase retinal ganglion cell survival. The disclosed method use exosomes and/or miRNA.
    Type: Application
    Filed: January 24, 2019
    Publication date: July 25, 2019
    Applicant: THE U.S. OF AMERICA, as represented by the Secretary, Department of Health and Human Services
    Inventors: Stanislav Ivanovich Tomarev, Benjamin Frank John Martin Mead